Characterizing genetic alterations related to radioiodine avidity in metastatic thyroid cancer.

Patients with I-RAIR pattern featured with mutations of BRAF and/or TERT promoter predominantly, of which, RAS mutations usually accompanied with late-hit mutations, while fusions mostly involved alone.